|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/00 |
| (11) | Patento numeris | 2364732 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11164996.8 |
| Europos patento paraiškos padavimo data | 2007-03-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-09-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-07-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 06111523 | 2006-03-22 | EP | |
| 06021815 | 2006-10-18 | EP |
| (72) |
Friess, Thomas, DE
Hasmann, Max, DE
Scheuer, Werner, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacher Strasse 124, 4070 Basel,
CH
|
| (54) | Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 |
| Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 |